These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19196220)

  • 21. Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers.
    Krishna G; Ma L; Prasad P; Moton A; Martinho M; O'Mara E
    Expert Opin Drug Metab Toxicol; 2012 Jan; 8(1):1-10. PubMed ID: 22176629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of oral posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.
    Krishna G; AbuTarif M; Xuan F; Martinho M; Angulo D; Cornely OA
    Pharmacotherapy; 2008 Oct; 28(10):1223-32. PubMed ID: 18823218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations.
    Walravens J; Brouwers J; Spriet I; Tack J; Annaert P; Augustijns P
    Clin Pharmacokinet; 2011 Nov; 50(11):725-34. PubMed ID: 21973269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of isavuconazole on tacrolimus and sirolimus serum concentrations in allogeneic hematopoietic stem cell transplant patients: A drug-drug interaction study.
    Kieu V; Jhangiani K; Dadwal S; Nakamura R; Pon D
    Transpl Infect Dis; 2019 Feb; 21(1):e13007. PubMed ID: 30295407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments.
    Agarwal SK; DiNardo CD; Potluri J; Dunbar M; Kantarjian HM; Humerickhouse RA; Wong SL; Menon RM; Konopleva MY; Salem AH
    Clin Ther; 2017 Feb; 39(2):359-367. PubMed ID: 28161120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent administration of sirolimus and voriconazole: a pilot study assessing safety and approaches to appropriate management.
    Surowiec D; DePestel DD; Carver PL
    Pharmacotherapy; 2008 Jun; 28(6):719-29. PubMed ID: 18503400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia.
    Arrieta AC; Sung L; Bradley JS; Zwaan CM; Gates D; Waskin H; Carmelitano P; Groll AH; Lehrnbecher T; Mangin E; Joshi A; Kartsonis NA; Walsh TJ; Paschke A
    PLoS One; 2019; 14(3):e0212837. PubMed ID: 30913226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trimethoprim-sulphamethoxazole does not affect the pharmacokinetics of sirolimus in renal transplant recipients.
    Böttiger Y; Brattström C; Bäckman L; Claesson K; Burke JT
    Br J Clin Pharmacol; 2005 Nov; 60(5):566-9. PubMed ID: 16236048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers.
    Krishna G; Moton A; Ma L; Medlock MM; McLeod J
    Antimicrob Agents Chemother; 2009 Mar; 53(3):958-66. PubMed ID: 19075045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and safety study of posaconazole intravenous solution administered peripherally to healthy subjects.
    Kersemaekers WM; van Iersel T; Nassander U; O'Mara E; Waskin H; Caceres M; van Iersel ML
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1246-51. PubMed ID: 25512407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.
    Sime FB; Stuart J; Butler J; Starr T; Wallis SC; Pandey S; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sotrastaurin and everolimus pharmacokinetics after single-dose coadministration.
    Kovarik JM; Bartlett M; Rordorf C; Antunes MC; Winter S; Marbach P; van Marle S
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):103-8. PubMed ID: 20137762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and tolerability of intravenous posaconazole in healthy Chinese volunteers: a randomized, open-label and single-dose study.
    Ji W; Zhao H; Yang S; Wen Q; He K
    Pharmazie; 2020 Oct; 75(10):491-493. PubMed ID: 33305723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sirolimus-itraconazole interaction in a hematopoietic stem cell transplant recipient.
    Said A; Garnick JJ; Dieterle N; Peres E; Abidi MH; Ibrahim RB
    Pharmacotherapy; 2006 Feb; 26(2):289-95. PubMed ID: 16466336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction.
    Fihlman M; Hemmilä T; Hagelberg NM; Kuusniemi K; Backman JT; Laitila J; Laine K; Neuvonen PJ; Olkkola KT; Saari TI
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1363-1371. PubMed ID: 27510521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.
    Djebli N; Rousseau A; Hoizey G; Rerolle JP; Toupance O; Le Meur Y; Marquet P
    Clin Pharmacokinet; 2006; 45(11):1135-48. PubMed ID: 17048977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of metabolic cytochrome P450 3A4 drug-drug interaction between everolimus and azole antifungals in a renal transplant patient.
    Billaud EM; Antoine C; Berge M; Abboud I; Lefeuvre S; Benammar M; Glotz D
    Clin Drug Investig; 2009; 29(7):481-486. PubMed ID: 19499965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of innovator versus generic cyclosporine via a drug interaction on sirolimus.
    Kovarik JM; Noe A; Wang Y; Mueller I; DeNucci G; Schmouder RL
    Eur J Clin Pharmacol; 2006 May; 62(5):361-6. PubMed ID: 16547714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4.
    Groll AH; Townsend R; Desai A; Azie N; Jones M; Engelhardt M; Schmitt-Hoffman AH; Brüggemann RJM
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28722255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.